Skip to main content
MOVE
NASDAQ Technology

Shareholders to Vote on Over 3,000% Dilution to Finalize Reverse Merger

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Negative
Importance info
9
Price
$18.68
Mkt Cap
$37.006M
52W Low
$3.439
52W High
$25.9
52W Position info
443% above low
Off High info
28% below high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

MOVE has more than doubled off its 52-week low of $3.439.

Summary

Corvex, Inc. shareholders will vote on proposals that would result in over 3,000% dilution to existing common stock, formalizing the equity structure of the recent reverse merger into an AI cloud computing business.


Key Events · Corporate Governance and Compliance · MOVE

  • Massive Share Dilution Proposed

    Shareholders will vote on issuing up to 68.6 million new shares to convert preferred stock, RSUs, and options from the recent reverse merger. This represents over 3,000% dilution to current common shareholders, effectively transferring control to the former Corvex OpCo securityholders.

  • New Equity Incentive Plans

    Proposals include approving a 2026 Equity Incentive Plan (3.5 million shares initially, plus 4% annual evergreen) and a 2026 Employee Stock Purchase Plan (900,000 shares initially, plus 2% annual evergreen), adding further potential dilution to the post-merger entity.

  • Auditor Change Ratification

    Shareholders will ratify the appointment of BDO USA, P.C. as the new independent auditor, following the previous auditor's report that included a "going concern" explanatory paragraph and material weaknesses.

  • Shareholder Meeting Scheduled

    The annual meeting is set for June 26, 2026, to vote on these critical proposals, which are essential for the company to comply with Nasdaq listing rules following its reverse merger.


Analysis · MOVE · Technology

This definitive proxy statement outlines critical proposals for the upcoming annual meeting, primarily seeking shareholder approval for the issuance of up to 68.6 million shares. This issuance is necessary to convert preferred stock, RSUs, and options related to the recent reverse merger with Corvex OpCo. If approved, existing shareholders will face over 3,000% dilution, effectively transferring control to the former Corvex OpCo securityholders. The filing also details the adoption of new, potentially dilutive equity incentive plans and the ratification of a new auditor following previous "going concern" and "material weaknesses" disclosures.

At the time of this filing, MOVE was trading at $18.68 on NASDAQ in the Technology sector, with a market capitalization of approximately $37M. The 52-week trading range was $3.44 to $25.90. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

MOVE - Latest Insights

MOVE
Jul 10, 2026, 5:10 PM EDT
Filing Type: S-1
Importance Score:
9
Price at Filing: $16.79
Real-time Price: $12.95 info
Change: -$3.84 (-23%) info
Market Cap: $350.974M info
MOVE
Jul 08, 2026, 8:13 PM EDT
Filing Type: SCHEDULE 13D
Importance Score:
9
Price at Filing: $16.54
Real-time Price: $12.95 info
Change: -$3.59 (-22%) info
Market Cap: $350.974M info
MOVE
Jul 08, 2026, 8:13 PM EDT
Filing Type: SCHEDULE 13D
Importance Score:
9
Price at Filing: $16.54
Real-time Price: $12.95 info
Change: -$3.59 (-22%) info
Market Cap: $350.974M info
MOVE
Jul 07, 2026, 5:10 PM EDT
Filing Type: 8-K
Importance Score:
10
Price at Filing: $16.67
Real-time Price: $12.95 info
Change: -$3.72 (-22%) info
Market Cap: $350.974M info
MOVE
Jun 26, 2026, 10:26 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $21.68
Real-time Price: $12.95 info
Change: -$8.73 (-40%) info
Market Cap: $350.974M info